To address medicine shortages and supply chain disruptions, this project introduces an agile manufacturing platform for pharmacies and hospital pharmacies. Using 3D-inspired robotic dosing, AI-driven analytics, RFID tracking, and workflow automation, the system ensures real-time, scalable, and regulatory-compliant production of essential medicines. By decentralising pharmaceutical manufacturing, it enables rapid responses to crises, reduces bottlenecks and waste, and enhances EU healthcare resilience.
- Beneficiaries
Coordinators: Curifylabs OY
Participants: AtrimusRx AB - Fysioline Oy - Pharmacie Delpech - Sihtasutus tartu ulikooli kliinikum - Universitaetsmedizin der Johannes Gutenberg-universitaet Mainz - Vaasan Hietalahden apteekki
- Project Locations
Finland - Sweden - France - Estonia - Germany
- EU contribution
€ 3 359 200.80
- Funding sources
Other STEP stories
PharmSD 3.0 will develop an integrated, continuous-pharmaceutical spray drying process to enhance efficiency, scalability, and cost-effectiveness.
This project develops an AI and robotic driven, decentralised pharmaceutical EU manufacturing platform to enhance crisis preparedness.
SmartNEBI will develop a sustainable, enzyme-based synthesis of heart-medicine nebivolol to enhance sustainability, scalability, and EU pharmaceutical sovereignty.